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Abstract
Fibromyalgia (FM) and hypermobility type Ehlers-Danlos syndrome (EDSH) share a series of common clinical
signs. A clinical distinction between both diseases is occasionally difficult to be established. The physical changes
observed in the mechanical properties of skin and joints do not distinctly distinguish these disorders. In addition,
similar ultrastructural dermal changes are observed in both EDSH and some FM cases. The molecular alterations
remain largely undisclosed in both diseases. As a result, EDSH remains undiagnosed in some FM patients. This
condition deteriorates quality of life and possibly leads to prominent health problems.
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Introduction
Ehlers-Danlos syndrome (EDS) represents a conglomeration of
distinct inherited genetic alterations in the molecular composition of
the connective tissue extracellular matrix. Currently, six major types
are recognized. Fibrillar collagen types are involved in the majority of
EDS cases. The dermis, particularly its reticular layer is conveniently
used for typing the molecular and ultrastructural EDS alterations [1].
Fibromyalgia (FM) is commonly evoked by widespread chronic
musculoskeletal pain, tenderness and reactive joint, tendon and muscle
stiffness, chronic fatigue, sleep disturbances and cognitive symptoms.
Widespread pain is present at least for 3 months, on both sides of the
body, both above and below the waist. The FM origin remains
unknown. The diagnosis is assessed by rating the widespread pain
index (WPI) endorsing 19 body regions, and a symptom severity score
(SSS) based on the evaluation of fatigue, sleep disturbances and
cognitive symptoms [2–5]. The combination with tender point refines
the establishment of the FM diagnosis [5]. FM is frequently associated
with joint laxity [6–14] representing a major diagnostic criterion of
benign joint hypermobility syndrome (JSH) [15] and of the autosomal
dominant hypermobility type Ehlers-Danlos syndrome (EDSH) [16–
18]. In addition, several other common signs exist between FM and
EDSH, including widespread pain, fatigue, anxiety, and functional
gastrointestinal disorders [16]. From that observation, some FM
presentations possibly represent an undiagnosed EDSH [19,20]. The
genetic mutations are largely undisclosed in EDSH, but ultrastructural
dermal abnormalities, although individually unspecific, appear
relevant and contribute to the diagnosis drawing-up [1,18,21].
Globally, FM, EDSH and JHS represent three overlapping connective
tissue disorders characterized by chronic and recurrent pain, joint
instability and minor skin changes. The molecular defects remain
unknown.
The dermal extracellular matrix is mainly composed of collagen and
elastic fibres admixed with amorphous glycoproteins and
glycosamimoglycans covalently linked to polypeptides to form
proteoglycans. Collagen fibrils represent by far the most abundant
component of the dermis. In normal subjects, they are present as a
finely woven meshwork. They are united into thick interlacing and
interconnected bundles in the reticulum dermis. In some connective
tissue disorders, the aspect and the cut surface of the collagen fibrils
are heterogeneous. These changes are best appreciated by combining
electron microscopy and computerized image analysis [22-26]. Three
main changes are possibly combined. First, wide variations are
occasionally disclosed in the diameter of rounded fibrils. Second, large
collagen fibrils with cauliflower shape and smaller serrated fibrils are
present. Third, the interfibrillar spacing is irregularly enlarged. The
EDSH diagnosis is tricky in absence of specific clinical clues and
molecular mutation. Hence, its frequency is probably underestimated
[20], and some FM possibly represents an undiagnosed EDSH. In our
experience, at least about 15 % of FM patients show EDSH signs.
We presently compare ultrastructural aspects of the skin in FM and
EDSH, searching for objective diagnostic criteria. We revisit the
ultrastructural aspects of the dermis in FM and EDSH.
Patients and methods
Over the past 7 years, one of us (THL) and her clinical staff
examined 73 FM patients (68 women and 5 men), who contributed to
a skin biopsy for ultrastructural assessments. Two 55 and 60 year-old
women, who suffered from long standing FM, had no signs of joint
laxity (0/9 Beighton score) nor EDSH family history. A total of 71
patients (66 women and 5 men), who were 15-70 year-old, had a
Beighton score ranging between 0 and 7/9, mostly 4 or 5/9. They
presented with a velvety and/or moderately hyperextensible skin,
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multiple minor EDSH signs such as sprains, joint (sub) luxations, easy
bruising, and enlarged atrophic scars, Gorlin sign and, occasionally, a
positive EDSH family history. Some patients had a 4/9 Beighton score,
that was too low for a diagnosis of typical EDSH, but fitted with JHS.
Some authors consider JHS as a minor form of EDSH [27-32]. Joint
laxity is influenced by gender, and regresses with age and repeat joint
micro traumatisms. A skin biopsy was taken from a sun protected area
such as the armpit and buttock in order to avoid prominent actinic
changes. The samples were fixed in 4% glutaraldehyde in phosphate
buffer at pH 4.7, post-fixed in 1% osmium tetroxide and embedded in
Epon. Semithin sections were stained with 0.5% toluidine blue.
Ultrathin sections were stained with uranyl acetate and lead citrate. A
Zeiss EM 910 electron microscope was operated at 60 kV.
Results
Skin ultrastructural examinations of the 71 FM patients with EDSH
signs and familial history, revealed abnormalities in collagen and
elastic fibers, and in other dermal components, similar to those found
in EDSH. Collagen bundles showed uneven rounded fibril sizes, some
flower-like collagen fibrils (Figure 1) and irregularly widened
interfibrillar spacing. Elastic fibers exhibited irregular contours (Figure
2). Such aspects were absent in skin samples from normal individuals
and from the two FM patients without EDSH clinical signs.
Figure1: Flower-like collagen fibril and uneven fibril sizes and
spacing.
Figure 2: Elastic fiber with irregular contour.
Discussion
At present, morphological observation of the dermal structure does
not represent an outdated approach. It allows a better understanding of
many connective tissue disorders in combination with molecular and
genetic evaluations when possible [1]. FM and EDSH share some
similar clinical aspects including joint laxity, chronic widespread pain,
chronic fatigue, sleep disturbance, functional gastrointestinal
manifestations and cognitive symptoms. Both FM and EDSH are more
prevalent in women than in men [4,33,34]. The FM pathogenesis
remains unclear, but the role of sex hormones seems to be limited
[35,36]. EDSH is considered to be linked to autosomal dominant
inheritance, but the role of sex hormones on the musculoskeletal
system possily explains the predominance of EDSH in women.
There is an absence of genetic and biochemical markers in FM and
EDSH, but skin ultrastructural abnormalities are well described in
EDSH. For such reasons, we used skin biopsies for comparing these
two pathological entities. Skin biopsy of some FM patients showed
some dermal ultrastructural abnormalities indistinct from those found
in EDSH. Such findings suggest that some FM types possibly represent
undiagnosed EDSH. Genetic and molecular basis similar to EDSH
might be considered as eventual candidates for the FM etiology.
Distinctive clinical criteria for EDSH and FM remain crude and
unsettled. Microscopy does not distinguish both conditions. We
conjecture about a clear-cut distinction between them. At present,
electron microscopy provides similar information for both conditions.
However, similarity does not mean common genetic and molecular
origin for both conditions although it possibly suggests the presence of
related defects. Of note, signs and symptoms suggesting FM are also
present in patients suffering from JSH [37]. Such cases are commonly
misdiagnosed EDSH, FM and JHS. They are considered in the field of
extracellular matrix disorders. The presently reported ultrastructural
findings are in line with such concept. The present study represents the
first attempt using skin ultrastruture for distinguishing EDSH and JHS
from FM. Our conclusions are in line with clinical opinions supporting
some similarities between these disorders, and perhaps common
molecular causes for these clinical challenges. A common
characteristic is the present of a non-inflammatory connective tissue
disorder with similar ultrastructural changes in the collagen and elastic
fibers. The impact on comorbidities and quality of life is frequent. Pain
and disability are occasionally prominent. The relationship between
EDSH, FM and JHS should be taken into consideration in the
diagnosis and follow-up of women. Such consideration has a broad
impact on chronic pain and daily life.
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